1. Rustum YM (1978) Metabolism and intracellular retention of 1-ß-D-arabinofuranosylcytosine as predictors of response of animal tumors. Cancer Res 38: 543–549
2. Kufe D, Spriggs D, Egan EM, Munroe D (1984) Relationship among ara-CTP pools, formation of (ara-C) DNA, and cytotoxicity of human leukemic cells. Blood 64: 54–58
3. Shewach DS, Plunkett W (1982) Correlation of cytotoxicity with total intracellular exposure to 9-ß-D-arabinofuranosyladenine 5′-triphosphate. Cancer Res. 42: 3637–3641
4. Plunkett W, Iacoboni S, Estey EH, Danhauser L, Liliemark JO, Keating MJ (1985) Pharmacologically directed ara-C therapy for refractory leukemia. Sem Oncol 12 (suppl): 20–30
5. Estey E, Plunkett W, Dixon DO, Keating M, McCredie K, Freireich EJ (1987) Variables predicting response to high dose cytosine arabinoside therapy with refractory acute leukemia. Leukemia 1: 580–583